| Molecular Weight | 427.4 g/mol |
|---|---|
| Molecular Formula | C20H21N5O6 |
| XLogP3 | 0.2 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 9 |
| Exact Mass | 427.14918341 g/mol |
| Monoisotopic Mass | 427.14918341 g/mol |
| Topological Polar Surface Area | 187 A^2 |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 748 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 2 | |
|---|---|
| Drug Name | Alimta |
| PubMed Health | Pemetrexed (Injection) |
| Drug Classes | Antineoplastic Agent |
| Drug Label | Pemetrexed disodium heptahydrate has the chemical name L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, disodium salt, heptahydrate. It is a white to almost-white solid with a molecular formula of C... |
| Active Ingredient | Pemetrexed; Pemetrexed disodium |
| Dosage Form | Injectable |
| Route | injection; Iv (infusion) |
| Strength | eq 500mg base/vial; 500mg; eq 100mg base/vial |
| Market Status | Prescription |
| Company | Lilly |
| 2 of 2 | |
|---|---|
| Drug Name | Alimta |
| PubMed Health | Pemetrexed (Injection) |
| Drug Classes | Antineoplastic Agent |
| Drug Label | Pemetrexed disodium heptahydrate has the chemical name L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, disodium salt, heptahydrate. It is a white to almost-white solid with a molecular formula of C... |
| Active Ingredient | Pemetrexed; Pemetrexed disodium |
| Dosage Form | Injectable |
| Route | injection; Iv (infusion) |
| Strength | eq 500mg base/vial; 500mg; eq 100mg base/vial |
| Market Status | Prescription |
| Company | Lilly |
